Antibiotics are arguably the most important class of drugs ever developed. They are also being squandered. The CDC estimates that at least thirty percent of outpatient antibiotic prescriptions in the United States are unnecessary, and the consequences — measured in resistant infections, longer hospital stays, and rising mortality — are no longer hypothetical. The problem is not exotic superbugs in distant labs. It is everyday prescribing for the wrong reasons.
What the resistance numbers actually look like
The CDC’s Antibiotic Resistance Threats reports estimate that antibiotic-resistant infections cause more than 35,000 deaths annually in the United States, with global figures from a 2022 Lancet study attributing roughly 1.27 million deaths worldwide to bacterial resistance in 2019. MRSA, carbapenem-resistant Enterobacteriaceae, and drug-resistant Neisseria gonorrhoeae are no longer rare findings — they are routine in major hospitals. The pipeline of new antibiotics has been thin for decades because the economics do not favor pharmaceutical investment in drugs meant to be used sparingly. We are spending down a finite resource and not replacing it.
Where the overprescribing happens
Most inappropriate prescribing is for viral infections — colds, bronchitis, sinusitis, and many sore throats — that antibiotics cannot touch. Studies in JAMA and the Annals of Internal Medicine have repeatedly found that patient pressure, time-constrained visits, and diagnostic uncertainty drive prescribers toward an antibiotic even when guidelines do not support it. Telehealth, retail clinics, and dental prescribing have been flagged in recent CDC stewardship reports as particularly prone to overuse. Agriculture is the other major contributor: roughly two-thirds of antibiotics by tonnage in the United States are used in livestock, often for growth promotion or routine prophylaxis rather than treatment, despite FDA rule changes intended to curb the practice.
What individuals can actually do
The patient-facing piece is unglamorous. Do not push for antibiotics for viral symptoms. If a clinician offers a “watchful waiting” prescription — a script you fill only if symptoms worsen — use it as intended. Finish prescribed courses or, increasingly per updated guidance, follow the shorter course your physician specifies, since recent evidence in journals like BMJ suggests longer-than-necessary courses also drive resistance. Do not save leftover antibiotics for self-treatment. On the food side, shifting demand toward producers with lower antibiotic use creates economic pressure that regulation has been slow to apply. None of these moves are dramatic. Resistance is a collective-action problem solved by millions of small changes.
The takeaway
Antibiotic resistance is not a future crisis to be solved later. It is a current and accelerating problem driven mostly by ordinary prescribing patterns, agricultural practice, and patient expectations. The drugs still work for most infections, but the margin is thinning. Each unnecessary course shortens the useful life of compounds we cannot replace at the rate we are losing them. Treating antibiotics as the precious finite resource they actually are — at the patient level, the clinician level, and the policy level — is the only path that has ever worked. There is no clever shortcut.
Leave a Reply